Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia

Patients with chronic eosinophilic pneumonia often experience recurring disease and prolonged corticosteroid use with adverse effects. Benralizumab enabled corticosteroid discontinuation and successfully treated chronic eosinophilic pneumonia in our study, confirmed through remission induction thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshiro Kai, MD, PhD, Yuichi Hishida, RT
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829325000918
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699337969336320
author Yoshiro Kai, MD, PhD
Yuichi Hishida, RT
author_facet Yoshiro Kai, MD, PhD
Yuichi Hishida, RT
author_sort Yoshiro Kai, MD, PhD
collection DOAJ
description Patients with chronic eosinophilic pneumonia often experience recurring disease and prolonged corticosteroid use with adverse effects. Benralizumab enabled corticosteroid discontinuation and successfully treated chronic eosinophilic pneumonia in our study, confirmed through remission induction therapy and 3-dimensional bronchial tree visualization.
format Article
id doaj-art-4a84778efb2a4842bddba7b59a60fb67
institution DOAJ
issn 2772-8293
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Journal of Allergy and Clinical Immunology: Global
spelling doaj-art-4a84778efb2a4842bddba7b59a60fb672025-08-20T03:18:38ZengElsevierJournal of Allergy and Clinical Immunology: Global2772-82932025-08-014310049010.1016/j.jacig.2025.100490Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumoniaYoshiro Kai, MD, PhD0Yuichi Hishida, RT1Department of Respiratory Medicine, Minami-Nara General Medical Center, Nara, Japan; Department of Respiratory Medicine, Nara Medical University, Nara, Japan; Corresponding author: Yoshiro Kai, MD, PhD, Department of Respiratory Medicine, Minami-Nara General Medical Center, 8-1 Fukugami, Oyodo-cho, Yoshino-gun, Nara 638-8551, Japan.Department of Radiology, Minami-Nara General Medical Center, Nara, JapanPatients with chronic eosinophilic pneumonia often experience recurring disease and prolonged corticosteroid use with adverse effects. Benralizumab enabled corticosteroid discontinuation and successfully treated chronic eosinophilic pneumonia in our study, confirmed through remission induction therapy and 3-dimensional bronchial tree visualization.http://www.sciencedirect.com/science/article/pii/S2772829325000918Benralizumabchronic eosinophilic pneumoniacorticosteroidremissionsevere asthmaeosinophilic lung disease
spellingShingle Yoshiro Kai, MD, PhD
Yuichi Hishida, RT
Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
Journal of Allergy and Clinical Immunology: Global
Benralizumab
chronic eosinophilic pneumonia
corticosteroid
remission
severe asthma
eosinophilic lung disease
title Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
title_full Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
title_fullStr Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
title_full_unstemmed Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
title_short Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
title_sort benralizumab treatment and 3 dimensional bronchial tree changes in chronic eosinophilic pneumonia
topic Benralizumab
chronic eosinophilic pneumonia
corticosteroid
remission
severe asthma
eosinophilic lung disease
url http://www.sciencedirect.com/science/article/pii/S2772829325000918
work_keys_str_mv AT yoshirokaimdphd benralizumabtreatmentand3dimensionalbronchialtreechangesinchroniceosinophilicpneumonia
AT yuichihishidart benralizumabtreatmentand3dimensionalbronchialtreechangesinchroniceosinophilicpneumonia